SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-16-090604
Filing Date
2016-03-28
Accepted
2016-03-28 16:01:49
Documents
60
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K v433857_10k.htm 10-K 748729
2 EXHIBIT 31.1 v433857_ex31-1.htm EX-31.1 11379
3 EXHIBIT 31.2 v433857_ex31-2.htm EX-31.2 11310
4 EXHIBIT 32.1 v433857_ex32-1.htm EX-32.1 5671
  Complete submission text file 0001144204-16-090604.txt   5183773

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT fencf-20151231.xml EX-101.INS 1281206
6 XBRL TAXONOMY EXTENSION SCHEMA fencf-20151231.xsd EX-101.SCH 57830
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE fencf-20151231_cal.xml EX-101.CAL 26807
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE fencf-20151231_def.xml EX-101.DEF 281482
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE fencf-20151231_lab.xml EX-101.LAB 330868
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fencf-20151231_pre.xml EX-101.PRE 319578
Mailing Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709
Business Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709 (919) 636-4530
FENNEC PHARMACEUTICALS INC. (Filer) CIK: 0001211583 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-32295 | Film No.: 161532269
SIC: 2836 Biological Products, (No Diagnostic Substances)